Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

20.71
-0.6200-2.91%
Volume:953.90K
Turnover:20.13M
Market Cap:2.86B
PE:-18.19
High:21.65
Open:21.42
Low:20.66
Close:21.33
52wk High:27.34
52wk Low:9.57
Shares:138.26M
Float Shares:118.91M
Volume Ratio:0.48
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1384
EPS(LYR):-5.0048
ROE:-37.11%
ROA:-5.96%
PB:5.48
PE(LYR):-4.14

Loading ...

Arrowhead Pharmaceuticals (ARWR) Receives a Hold from Bernstein

TIPRANKS
·
Aug 22

Arrowhead Pharmaceuticals (ARWR) Gets a Hold from Bernstein

TIPRANKS
·
Aug 18

Chief Medical Officer James C. Hamilton Reports Disposal of Common Shares of Arrowhead Pharmaceuticals Inc

Reuters
·
Aug 16

Stock Track | Arrowhead Pharmaceuticals Plummets 8.28% as Sarepta Therapeutics Offloads $174 Million in Stock

Stock Track
·
Aug 14

Stock Track | Arrowhead Pharmaceuticals Plummets 8.28% as Sarepta Therapeutics Sells $174 Million Stake

Stock Track
·
Aug 14

Stock Track | Arrowhead Pharmaceuticals Plunges 5.50% Pre-market as Sarepta Offloads $174 Million in Stock

Stock Track
·
Aug 14

Sarepta loses credibility by exiting Arrowhead at loss, says H.C. Wainwright

TIPRANKS
·
Aug 14

Sarepta Sells $174 Million Arrowhead Stock

MT Newswires Live
·
Aug 14

Arrowhead redeems $50M of common stock

TIPRANKS
·
Aug 14

Sarepta Therapeutics Advances siRNA Program with Milestone Payment to Arrowhead and Announces Preliminary Data Release for SRP-1003 in 2025

Reuters
·
Aug 14

Stock Track | Arrowhead Pharmaceuticals Soars 12.25% on Analyst Confidence and Milestone Payment

Stock Track
·
Aug 14

Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone From Sarepta Therapeutics

THOMSON REUTERS
·
Aug 14

Stock Track | Arrowhead Pharmaceuticals Soars 5% After H.C. Wainwright Reiterates Buy Rating

Stock Track
·
Aug 13

Stock Track | Arrowhead Pharmaceuticals Soars 5% After Analyst Reiterates Buy Rating and $80 Price Target

Stock Track
·
Aug 13

Arrowhead Pharmaceuticals: Positioned for Growth with Pivotal siRNA Program and Expanding Pipeline

TIPRANKS
·
Aug 13

Arrowhead Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for CFO Daniel Joseph Apel

Reuters
·
Aug 13

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), DENTSPLY SIRONA (XRAY) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Arrowhead Pharmaceuticals (ARWR) and Travere Therapeutics (TVTX)

TIPRANKS
·
Aug 11

Arrowhead Pharmaceuticals Is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 09

Stock Track | Arrowhead Pharmaceuticals Plummets 5.21% in Pre-market After Q3 Earnings Miss

Stock Track
·
Aug 08